SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-040924
Filing Date
2023-08-10
Accepted
2023-08-10 06:31:57
Documents
80
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q fnch-20230630.htm   iXBRL 10-Q 2205826
2 EX-10.5 fnch-ex10_5.htm EX-10.5 384032
3 EX-10.6 fnch-ex10_6.htm EX-10.6 765132
4 EX-10.7 fnch-ex10_7.htm EX-10.7 216823
5 EX-31.1 fnch-ex31_1.htm EX-31.1 22347
6 EX-31.2 fnch-ex31_2.htm EX-31.2 22654
7 EX-32.1 fnch-ex32_1.htm EX-32.1 22388
8 GRAPHIC img120795611_0.jpg GRAPHIC 3442
  Complete submission text file 0000950170-23-040924.txt   9386157

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fnch-20230630_def.xml EX-101.DEF 158844
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fnch-20230630_cal.xml EX-101.CAL 48776
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fnch-20230630_pre.xml EX-101.PRE 294684
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fnch-20230630_lab.xml EX-101.LAB 388643
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fnch-20230630.xsd EX-101.SCH 46591
74 EXTRACTED XBRL INSTANCE DOCUMENT fnch-20230630_htm.xml XML 1442405
Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 617-229-6499
Finch Therapeutics Group, Inc. (Filer) CIK: 0001733257 (see all company filings)

IRS No.: 823433558 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40227 | Film No.: 231157091
SIC: 2836 Biological Products, (No Diagnostic Substances)